Prenatal drug exposure affects neonatal brain functional connectivity

Andrew P Salzwedel1, Karen M Grewen2, Clement Vachet3

  • 1Department of Radiology and Biomedical Research Imaging Center and.

Insights

Prenatal cocaine exposure (PCE) disrupts infant brain connectivity, particularly in arousal regulation networks. This study reveals early neural changes, aiding in risk identification and intervention for prenatal drug exposure effects.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Radiology

Background:

  • Prenatal drug exposure, especially cocaine, has known neurodevelopmental consequences.
  • Neural underpinnings of prenatal cocaine exposure (PCE) are poorly understood, particularly in neonates.
  • Existing studies are often confounded by postnatal environmental factors.

Purpose of the Study:

  • To characterize the earliest neural correlates of PCE using functional connectivity.
  • To investigate the impact of PCE on amygdala and insula connectivity in neonates.
  • To differentiate cocaine-specific effects from general poly-drug exposure impacts.

Main Methods:

  • Utilized resting-state functional magnetic resonance imaging (fMRI) in a large neonate sample (N=152).
  • Compared infants with PCE (and other drug exposures) to controls with non-cocaine poly-drug exposure and drug-free infants.
  • Focused on functional connectivity within amygdala-frontal and insula-related circuits.

Main Results:

  • Identified common drug exposure-related disruptions in amygdala-frontal, insula-frontal, and insula-sensorimotor circuits.
  • Detected a cocaine-specific connectivity alteration within an amygdala-frontal network subregion.
  • This cocaine-specific pathway is implicated in arousal regulation, found to be irregular in PCE.

Conclusions:

  • Provides the earliest human-based functional evidence of PCE's neurodevelopmental impact.
  • Highlights specific connectivity disruptions in neonates exposed to cocaine prenatally.
  • Opens avenues for early risk identification and targeted interventions for prenatal drug exposure.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K